Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
BMC Infectious Diseases|January 19, 2020
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trialA Abdulla, T M J Ewoldt, N G M Hunfeld, et al.
Pediatric Blood & Cancer|February 17, 2017
Drug-drug interactions in pediatric oncology patientsT E Balk, I H van der Sijs, T van Gelder, et al.
International Journal of Biometeorology|February 19, 2013
Larger antelopes are sensitive to heat stress throughout all seasons but smaller antelopes only during summer in an African semi-arid environmentA K Shrestha, S E van Wieren, F van Langevelde, et al.
European Journal of Clinical Pharmacology|July 7, 2017
Population pharmacokinetics of haloperidol in terminally ill adult patientsL G Franken, R A A Mathot, A D Masman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapyD A Hesselink, T van Dam, H J Metselaar, et al.
Transplantation|September 26, 2001
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppressionB J van der Mast, N M van Besouw, P de Kuiper, et al.
Patient Education and Counseling|December 20, 2015
Kidney transplant patients' attitudes towards self-management support: A Q-methodological studyJ W Grijpma, M Tielen, A L van Staa, et al.
Transplantation|March 4, 1998
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humansT van Gelder, C C Baan, A H Balk, et al.
Clinical and Experimental Immunology|May 3, 2002
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantationN M van Besouw, B J van der Mast, P de Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2011
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patientsM S Marcolino, E Boersma, N C D Clementino, et al.
Pageof 15